Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma

21 Jan 2021

Abstract excerpt

Objective: The purpose of this study was to develop and validate a novel immune checkpoint–related gene signature for prediction of overall survival (OS) in hepatocellular carcinoma (HCC). Methods: mRNA expression profiles and clinical follow-up information were obtained in the International Cancer Genome Consortium database. An external dataset from The Cancer Genome Atlas (TCGA) Liver Hepatocellular Carcinoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33553243
DOI: 10.3389/fmolb.2020.620765

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular CarcinomaPMID 33553243Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

Immune‐related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinomaSemantic proximity Read ↗

A Novel lncRNA–mRNA Integrated Prognostic Signature Predicts Survival and Immune Checkpoint Landscape in Hepatocellular CarcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinomaSemantic proximity Read ↗

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinomaSemantic proximity Read ↗

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinomaSemantic proximity Read ↗

Establishment and Validation of an Anoiki-Associated Gene Signature Capable of Predicting Hepatocellular Carcinoma-related Immune Cell Infiltration and Prognostic OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.